RxDoctor Payments Data

William Richardson, MD

Internal Medicine · Avon, OHNPI 1659363752

Payments from drug & device makers

$1,466in general payments, 2019–2025

Across 89 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$208
  • AbbVie$106
  • AstraZeneca$86
  • Astellas Pharma US Inc$84
  • Johnson & Johnson$75
  • Merck$67
  • plus $840 from 26 others

What the payments were for

  • Food & beverage$1,466100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,466 in reported general payments places this provider in the 75th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$174,037
Medicare patients
455
Services billed
1,847

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban358$175,880
MounjaroTirzepatide155$170,817
XareltoRivaroxaban175$101,729
IngrezzaValbenazine Tosylate12$97,179
JardianceEmpagliflozin133$78,234
TrulicityDulaglutide59$74,638
RybelsusSemaglutide60$74,093
NuplazidPimavanserin Tartrate13$66,122
FanaptIloperidone39$61,766
OzempicSemaglutide33$51,026
JanuviaSitagliptin Phosphate87$46,446
TradjentaLinagliptin31$28,541
FarxigaDapagliflozin Propanediol34$23,281
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$18,680
Atorvastatin Calcium1,231$17,120

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$59$245,456214 claims
PfizerEliquis$49$175,880358 claims
Novo NordiskRybelsus, Ozempic$208$125,11893 claims
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$61$113,713178 claims
Johnson & JohnsonXarelto$75$101,729175 claims
Neurocrine Biosciences, Inc.Ingrezza$47$97,17912 claims
MerckJanuvia$67$46,44687 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$86$44,01279 claims
GSKTrelegy Ellipta$47$18,68024 claims
Astellas Pharma US IncMyrbetriq$84$16,42759 claims
AbbVieLinzess$106$14,98224 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Avon

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →